蘭太實業(600328.SH):標的資產氯鹼化工、高分子公司等均已完成過户手續
格隆匯12月27日丨蘭太實業(600328.SH)公佈,公司收到中國證監會的核準文件後積極開展標的資產交割工作,截至公告日,此次發行股份及支付現金購買資產並募集配套資金暨關聯交易事項之標的資產中鹽吉蘭泰氯鹼化工有限公司(“氯鹼化工”)、中鹽吉蘭泰高分子材料有限公司(“高分子公司”)、中鹽吉蘭泰鹽化集團有限公司純鹼廠(“純鹼廠”)、中鹽崑山有限公司(“中鹽崑山”)已完成過户手續。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.